Manufacturers and wholesale distributors prohibited from limiting pharmacy access to 340B drugs.

This bill prohibits drug manufacturers and wholesale distributors from blocking pharmacies that have contracts with 340B covered entities from receiving discounted 340B drugs. It requires these companies to deliver such medications directly to the pharmacies unless federal law explicitly forbids the transfer. The legislation aims to ensure that pharmacies serving specific healthcare organizations can access lower-cost medications without interference from suppliers.